Your browser doesn't support javascript.
loading
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.
Gonzalez-Lugo, Jesus D; Kambhampati, Suman; Yacoub, Abdulraheem; Donnellan, William B; Berdeja, Jesus; Bhagat, Prafulla; Fehn, Karen; Remy, Cassady; Jasra, Sakshi; Kazemi, Mohammed; Pradhan, Kith; Kim, Mimi; Mantzaris, Ioannis; Sica, R Alejandro; Shah, Nishi; Goldfinger, Mendel; Kornblum, Noah; Gritsman, Kira; Braunschweig, Ira; Steidl, Ulrich; Will, Britta; Shastri, Aditi; Verma, Amit.
Afiliação
  • Gonzalez-Lugo JD; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Kambhampati S; Sarah Cannon Transplant and Cellular Therapy Program, Kansas City, Kansas.
  • Yacoub A; University of Kansas Cancer Center, Westwood, Kansas.
  • Donnellan WB; Tennessee Oncology, Chattanooga, Tennessee.
  • Berdeja J; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Bhagat P; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Fehn K; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Remy C; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Jasra S; University of Vermont Cancer Center, Burlington, Vermont.
  • Kazemi M; Astera Cancer Care, East Brunswick, New Jersey.
  • Pradhan K; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Kim M; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York.
  • Mantzaris I; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Sica RA; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Shah N; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Goldfinger M; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Kornblum N; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Gritsman K; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Braunschweig I; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Steidl U; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Will B; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York.
  • Shastri A; Division of Hemato-Oncology, Department of Oncology, Montefiore Einstein Cancer Center, Blood Cancer Institute, Bronx, New York.
  • Verma A; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York.
Clin Cancer Res ; 29(1): 60-66, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36255372
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzoatos / Síndromes Mielodisplásicas / Lenalidomida Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzoatos / Síndromes Mielodisplásicas / Lenalidomida Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article